2015
DOI: 10.1002/adhm.201500040
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology

Abstract: In recent years, the exploitation of phenomena surrounding microfluidics has seen an increase in popularity, as researchers have found a way to use their unique properties to create superior design alternatives. One such application is representing the properties and functions of different organs on a microscale chip for the purpose of drug testing or tissue engineering. With the introduction of "organ-on-a-chip" systems, researchers have proposed various methods on various organ-on-a-chip systems to mimic the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
124
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 175 publications
(126 citation statements)
references
References 131 publications
1
124
0
Order By: Relevance
“…There are the two general strategies in generating organ models: bottom-up and top-down approaches. [27,29,[31][32][33][34] In a top-down approach, the strategy employed is to engineer individual components of a tissue environment that, together, mimic and recreate aspects of the system. For example, cellular components can be integrated by co-culturing multiple cell types in defined physical arrangements, 3D organization can be mimicked with biomaterial scaffolds and microfluidic channels, mechanical cues can be presented by biomaterials and fluid flow, and soluble stimuli can be delivered via perfusion.…”
Section: Engineering Technologiesmentioning
confidence: 99%
See 1 more Smart Citation
“…There are the two general strategies in generating organ models: bottom-up and top-down approaches. [27,29,[31][32][33][34] In a top-down approach, the strategy employed is to engineer individual components of a tissue environment that, together, mimic and recreate aspects of the system. For example, cellular components can be integrated by co-culturing multiple cell types in defined physical arrangements, 3D organization can be mimicked with biomaterial scaffolds and microfluidic channels, mechanical cues can be presented by biomaterials and fluid flow, and soluble stimuli can be delivered via perfusion.…”
Section: Engineering Technologiesmentioning
confidence: 99%
“…Indeed, engineered 3D cultures have already been used to model how humans to metabolize drugs through the interactions among multiple organs. [23][24][25][26][27][28][29][30] In this review, we provide a perspective on the three-major emerging 3D culturing technologies: 3D organoids, 3D microfabrication, and 3D bioprinting. As those technologies enable the modeling of the crucial features of human 3D organs essential to advance drug discovery, this review is based on the www.advancedsciencenews.com www.advhealthmat.de technologies used rather than on the organ mimicked.…”
mentioning
confidence: 99%
“…Organon-a-chip or body-on-a-chip systems are, however, in the proofof-concept stage, and many issues regarding their practical use remain to be improved. 11 Although many studies on micromodels of drug absorption or metabolic processes have been reported to date, 12-14 few organ-on-a-chip studies on drug excretion processes have been conducted. While many kidney-on-a-chip studies have been reported, most of them focused on the nephrotoxicity rather than renal excretion.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, additional applications of tissue engineering have emerged, as replacement for animal use in research, in the form of micro-organs or organs on a chip [3]. A key element in tissue engineering is the manufacture of a tissue scaffold, an extracellular matrix [7].…”
Section: Introductionmentioning
confidence: 99%